Monash IVF responds to ASX after baby bungle share price drop
Monash IVF has responded to a “please explain” from the Australian Securities Exchange over its recent baby bungle in Brisbane, saying it didn’t expect the “isolated incidence of human error” to affect the share price.
A woman unknowingly gave birth to a stranger’s baby after the wrong embryo was transferred in 2023.
The major fertility company became aware of the mix-up in February after the birth parents asked to transfer their remaining frozen embryos to another provider.
It reported the incident to regulators including Queensland Health — the state’s assisted reproductive technology regulator under new laws passed last year.
After the bungle made news headlines earlier this month, Monash IVF’s share price dropped from $1.08 to a low…
